2018 to 2022 Saw Increase in GLP-1 Receptor Agonist Use in Adults Without Diabetes

THURSDAY, April 10, 2025-- Among U.S. adults without diabetes, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) increased from 2018 to 2022, reaching annual prevalence of 0.4 percent in 2022, according to a study published online...